Pediatrics Department

The Department of Pediatrics, Beijing Anzhen Hospital, Capital Medical University, is a comprehensive clinical department integrating pediatric medical care, teaching, and research. It currently has 12 doctors, 19 nurses, and 20 beds. Six staff members have master’s degrees or above. It undertakes the theoretical teaching of pediatrics and clinical internship and clerkship for undergraduates of the Sixth Clinical Medical College of Capital Medical University; it also undertakes teaching for master’s and doctoral students; it provides internship teaching for the International Medical School of Capital Medical University; and it undertakes multiple fund projects and research programs.
It engages in the diagnosis, treatment, and rescue of common pediatric diseases, frequently occurring diseases, complex and difficult diseases, perinatal and neonatal health care and common diseases, and critical illnesses. It has unique insights especially in pediatric cardiovascular diseases, respiratory diseases, and autoimmune diseases. In December 2018, the pediatric team was approved as one of Beijing’s first batch of clinical key specialty construction projects.
Under the leadership of the current department director, Professor Liu Guiying, the department develops characteristic subspecialty directions and undertakes a large number of rescue and treatment tasks for pregnant women with severe cardiovascular diseases, newborns, and extremely preterm and extremely low birth weight newborns. It has reached internationally leading levels in neonatal critical care capacity and comprehensive cardiovascular assessment and treatment of newborns.
It also admits children with systemic diseases complicated by cardiovascular diseases (myocardial injury, myocarditis, arrhythmia, various cardiomyopathies, hypertension, heart failure, etc.), children’s respiratory diseases (pneumonia, asthma, etc.), endocrine diseases (diabetes, thyroid diseases, obesity, etc.), and connective tissue diseases (Kawasaki disease, Henoch-Schönlein purpura, systemic lupus erythematosus, rheumatic fever, Takayasu arteritis, etc.). It has taken the lead in promoting the national homogenization of diagnosis and treatment of pediatric myocarditis. For hereditary cardiovascular diseases, a whole-life-cycle and whole-family management model for myocardial diseases has been established from the neonatal period to adulthood.